Connect Biopharma Holdings Ltd. (CNTB)
2.07
+0.06
(+2.99%)
USD |
NASDAQ |
Sep 10, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Total Assets (Quarterly) : 43.47M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.47M |
| March 31, 2026 | 60.07M |
| December 31, 2025 | 56.08M |
| Date | Value |
|---|---|
| September 30, 2025 | 67.36M |
| June 30, 2025 | 82.72M |
| March 31, 2025 | 92.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.61M |
| Shareholders Equity (Quarterly) | 26.86M |
| Debt to Equity Ratio | 0.0222 |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | 0.05% |